Skip to search formSkip to main contentSkip to account menu

Buprenorphine Transdermal Matrix Patch

Known as: Transdermal Buprenorphine 
A transdermal matrix patch containing the synthetic opioid buprenorphine with analgesic and sedative activities. Buprenorphine binds to and activates… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Objectives To assess the effectiveness and tolerability of buprenorphine for cancer pain in adults and children. Methods We… 
Review
2012
Review
2012
Abstract Objective: To assess patients’ perceptions regarding the low-dose 7-day buprenorphine transdermal patch for treatment of… 
Review
2012
Review
2012
SUMMARY This systematic review compares convenience of administration, adverse events and tolerability of buprenorphine patch… 
2009
2009
We present three cases of children (aged 3–5 years) in which cancer‐related pain was adequately controlled by Transdermal… 
2008
2008
Background:  Buprenorphine is a low‐molecular‐weight, lipophilic, opioid analgesic. The transdermal delivery system (TDS… 
2006
2006
We carried out a cost-effectiveness evaluation of transdermal fentanyl compared to three other widely used opioids: transdermal… 
2006
2006
Buprenorphine is a semi‐synthetic opioid derived from thebaine. The transdermal formulation of buprenorphine has been available… 
2005
2005
ZusammenfassungAnhand von 4 Falldarstellungen werden die Besonderheiten der Opioidtherapie bei chronischen Schmerzen im…